National Strategic Plan of Ministry of Health 2015-2019
Los presentes Lineamientos tecnicos del ministerio de salud de El Salvador establece las disposiciones para la prevención y control de la tuberculosis, para su aplicación por el personal del Sistema Nacional Integrado de Salud para incidir en la r...educción de la morbimortalidad causada por la enfermedad. Este documento tiene como enfoqe especial el tuberculosis y la diabetes. Incluye propositos de promocion de salud con la participación comunitaria para el control de la tuberculosis. Ademas propone una educacion de salud con enfasis en tuberculosis.
more
Raport național, 2014
Chișinău – 2015
To understand the national situation, Ethiopia did a situation assessment, launched its first strategy in 2011, and took action to contain AMR, as detailed in the blue boxes found throughout this strategy. This updated version of the strategy was in... response to the revised health and medicines policies, health sector transformation plan, and the resolutions of the 68th World Health Assembly
of May 2015 and so that Ethiopia’s efforts could be coordinated with global initiatives in the prevention and containment of AMR.
more
Protocol clinic naţional
PCN- 123
El Laboratorio de Micología del Centro Nacional de Salud Pública del Instituto Nacional de Salud (INS) ha elaborado el presente manual de procedimientos micológicos, a fin de actualizar y uniform...izar los conocimientos referidos al diagnóstico micológico que se basa en la identificación precisa de los agentes causales de las micosis, aislados a partir de muestras clínicas representativas, así como también en pruebas de susceptibilidad antifúngica.
more
Edición General: Dirección Nacional de Normatización - MSP
Este manual ha sido desarrollado por profesionales de las instituciones del Sistema Nacional de Salud (SNS)
y especialistas expertos ...en la materia, bajo la coordinación de la Dirección Nacional de Normatización del
Ministerio de Salud Pública (MSP) y la colaboración de la Organización Panamericana de la Salud (OPS).
Contempla lineamientos técnicos, operacionales y administrativos, con la finalidad de garantizar la atención
integral, oportuna y de calidad a los usuarios de los establecimientos del SNS, dando prioridad a la preven-
ción, detección, diagnóstico y tratamiento para el control de la TB.
Los autores han declarado no tener conflicto de interés y han procurado ofrecer información completa y
actualizada; sin embargo, en vista de los posibles cambios en las ciencias médicas, se recomienda revisar el
prospecto de cada medicamento que se planea administrar, para cerciorarse de que no se hayan producido
cambios en las dosis sugeridas o en las contraindicaciones para su administración. Esta recomendación cobra
especial importancia en el caso de medicamentos nuevos o de uso infrecuente
more
El Programa Nacional de Chagas ha definido la utilización de dos medicamentos para el tratamiento de la Enfermedad de Chagas Crónico Reciente Infantil (en niños de 9 meses a menor de 15 años); el benznidazol (BNZ) que será utilizado como medica...mento de primera elección en todos los casos con diagnóstico serológico positivo confirmado y el nifurtimox (NFT) que será utilizado como segunda alternativa en aquellos casos que hubieran presentado reacciones adversas graves al benznidazol, e indiquen un cambio de conducta.
more
This user guide is designed to provide national malaria control programmes with general information on glucose-6-phosphate dehydrogenase (G6PD) deficiency. Individuals with this condition may be at risk of adverse effects from medicines commonly use...d to cure Plasmodium vivax malaria, as well as from other medicines and substances.
more
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, malaria and tuberculosis medicines. It describes how PS function...s in the country, what actors are involved in this area and the relations among them, pursuing salient issues in the modus operandi of partners in cooperation.
more
The Kenya Essential Medicines List 2019 is an indispensable guide to the medicines recommended for the management of common conditions in Kenya. It is primarily directed at health care providers and medicines supply managers in the public and non-public health sectors. It should be used together wit...h the current versions of updated national clinical guidelines for those conditions for which such guidelines exist
more
SIGN 143. A national clinical guideline
Published May 2015, Revised 2018
22nd edition
The purpose of the SAHR has always been to analyse and assess progress and challenges in key areas of the health system, and to propose recommendations for improvement. We are pleased to continue this tradition in the 2019 edition, which presents a unique collection of perspectives on ...the key challenges in implementing universal health coverage (UHC) in South Africa, as analysed by experts in various fields.
Each of the 20 chapters deals with aspects of the UHC journey, dedicated towards an equitable and inclusive national health system that leaves no-one behind. While some authors describe the fundamental changes and practical considerations required to reconfigure the country's health system, others have reflected on specific programmatic areas and have made recommendations from a National Health Insurance (NHI)/UHC lens.
more
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential medicines as an integral component of treatment within the continuum of... care, developing and disseminating the Model List of Essential Medicines (Model List). WHO is committed to supporting Member States in sharing best practices in selecting
essential medicines, and in developing processes for the selection of medicines for national essential medicines lists (national EMLs, or NEMLs) consistent with the evidence-based methods used for updating the WHO Model List.
more
Norma técnica para el control y la eliminación de la tuberculosis programa nacional de control y eliminación de la tuberculosis - Actualización 2021 Resolución Exenta N°60 del Ministerio de Salud, con fecha 14 de enero de 2022
The primary audience of these recommendations includes healthcare providers who are responsible for developing national and local health protocols (particularly those related to hypertensive disorders of pregnancy), and those directly providing care... to pregnant women and their newborns, including midwives, nurses, general medical practitioners, obstetricians, obstetric physicians, managers of maternal and child health programmes, and relevant staff in ministries of health, in all settings.
more
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that demand from Member States and is anchored in public... health guiding principles in the human health sector. It aims to provide a set of evidence-based and pragmatic recommendations to drive comprehensive and integrated AMS activities under the purview of a central national coordination unit, National AMR steering or coordinating committees or other equivalent national authorities.
Available in English, French, Spanish, Russian, Arabic, Chinese
more
La política de salvaguarda infantil de la CBM se basa en la Convención sobre los Derechos del Niño de la ONU de 1989 (y en sus protocolos facultativos) y en la legislación nacional de protección infantil de Alemania, así como en la de los paí...ses participantes en el programa de la CBM y la normativa de Keeping Children Safe. Esta política ha sido creada porque la seguridad y el respeto a la dignidad de todos los niños y las niñas es un principio básico del trabajo de la CBM. A efectos de esta política, se considera niño o niña a cualquier persona de menos de 18 años de edad.
more
PQM conducted an assessment of the medicine quality assurance and quality control systems in Rwanda during November 9-13, 2009. Medicine quality assurance remains to be developed in Rwanda: the country has neither a medicine regulatory authority (MRA) nor a ...">national medicine quality control laboratory – the two key institutions to ensure the quality, safety, and efficacy of medicines. The MOH Pharmacy Taskforce (PTF) is to be commended however for successfully controlling the pharmaceutical market to the extent that there is no informal medicines market in Rwanda. Based on its findings, the assessment team expects Rwanda to be able to make great strides in evidence-based medicines quality assurance in the short to medium term, provided it receives adequate technical assistance and financial support.
more
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effec...tive consumer reporting system within their pharmacovigilance centre. Throughout this document, the phrase “consumer reporting” is used to refer to reporting of adverse drug reactions (ADRs) by the general public.
more